As soon after treatment with Chk inhibitor, c-Jun protein levels increased in all B-ALL cell lines but not in all T-ALL cell lines in which the response to the treatment was very heterogeneous (Additional file 1: Figure S8-A). The gene discussed is JUN; the disease is acute lymphoblastic leukemia.